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 Abstract: 
 
 
Background 
Vitamin D has attracted considerable interest in recent years, and healthcare providers have 
reported large increases in vitamin D test requests. However, rates of diagnosis of vitamin D 
deficiency in clinical practice have not been investigated. We examined trends in the 
diagnosis of vitamin D deficiency in children in England over time, and by sociodemographic 
characteristics. 
 
Methods 
Cohort study using primary care electronic health records held in The Health Improvement 
Network database. 711 788 children aged 0-17 years were included. Incidence rates for 
diagnosis of vitamin D deficiency were calculated in each year between 2000-2014. Rate 
ratios exploring differences by age, sex, ethnicity, and social deprivation were estimated using 
multivariable Poisson regression. 
 
Results 
The crude rate of vitamin D deficiency diagnosis increased from 3.14 per 100 000 person-
years in 2000 (95% confidence interval [CI]: 1.31-7.54) to 261 per 100 000 person-years in 
2014 (95% CI: 241-281). After accounting for changes in demographic characteristics, a 15-
fold (95% CI: 10-21 fold) increase in diagnosis was seen between 2008-2014. Older age (≥10 
years), non-white ethnicity, and social deprivation were independently associated with higher 
rates of diagnosis. In children aged <5 years diagnosis rates were higher in boys than girls, 
whilst in children aged ≥10 they were higher in girls. 
 
Conclusions 
There has been a marked increase the diagnosis of vitamin D deficiency in children over the 
past decade. Future research should explore the drivers for this change in diagnostic 
behaviour and the reasons prompting investigation of vitamin D status in clinical practice. 
  
 Introduction 
 
Vitamin D has attracted considerable clinical and academic interest over the last two decades. 
Regional studies and hospital case series in the United Kingdom (UK), United States (US), 
and Australia have suggested an increase in numbers of children presenting with symptomatic 
complications of vitamin D deficiency (rickets and hypocalcaemia).1–3 Furthermore, a large 
body of observational research has stimulated debate regarding the postulated role of vitamin 
D in modifying the risk of developing various diseases beyond its established function in 
bone metabolism and calcium homeostasis.4 
 
As vitamin D has attracted increasing attention, hospitals in Australia and the UK have 
reported a surge in test requests.5,6 Primary care spending on vitamin D prescriptions in 
England increased from £28 million to £92 million between 2004-2014.7,8 Given the high 
prevalence of biochemical vitamin D deficiency in the general population, and uncertainty 
that treatment of asymptomatic individuals leads to improved health outcomes, some authors 
have questioned whether the large growth in testing may result in unnecessary health care 
costs and potential over-diagnosis.4,5,9 However, there has not been any empirical 
investigation of rates of diagnosis of vitamin D deficiency in clinical practice, and trends in 
testing and treatment have not been examined in children specifically. Using a large, 
population-based cohort of children in England, we determined longitudinal trends in rates of 
vitamin D deficiency diagnosis over the past 15 years, and explored differences by socio-
demographic characteristics. 
 
 
Methods 
 
 Data Source 
 
We conducted a dynamic (open) cohort study using The Health Improvement Network 
(THIN) primary care database, which contains anonymised electronic health records of >11 
million patients from 639 UK general practices.  The THIN cohort is broadly representative 
of the UK population in terms of age, sex, prevalence of medical conditions, and mortality 
rates.10 THIN includes data regarding medical diagnoses, laboratory test results, medication 
prescriptions, and socio-demographic characteristics. Diagnoses are recorded using a 
hierarchical coding system called Read codes.11 Diagnoses made in secondary care may be 
coded from discharge summaries and outpatient letters. A subset of THIN practices in 
England (n=156) are linked to patient-level Hospital Episode Statistics (HES) data, available 
up to 31st March 2012. HES contains records of all hospital care episodes in England, 
although clinical diagnoses are only recorded for inpatient admissions. We used linked HES 
data to augment information regarding ethnicity. 
 
 
Study Population 
 
Children aged 0-17 years registered with a THIN practice linked to HES, at any point between 
1st January 2000 and 31st December 2014, were included. Children with chronic renal disease, 
liver disease, or conditions associated with gastrointestinal malabsorption were excluded. The 
start of the observation period for each child was the latest of the date of practice registration 
(plus 3 months for children aged ≥1 year at registration), the date the practice met two pre-
defined quality indicators for electronic data recording (acceptable mortality recording 
[AMR] and acceptable computer usage [ACU]),12,13 and 1st January 2000. Diagnoses recorded 
shortly after patient registration can represent historical information transferred from medical 
 records rather than incident events.14 We observed greater recording of vitamin D deficiency 
diagnosis in the first 3 months after registration, therefore we excluded this period from 
observation for children aged ≥1 year at registration. The AMR and ACU criteria identify 
periods of incomplete use of computerised systems in primary care (e.g. following transition 
from paper records), and are described elsewhere.12,13 Exit from the observation period for 
each individual was the earliest of the date they transferred to a different practice, the date the 
practice stopped contributing data to THIN, the mid-point of their 18th year after birth, the 
date they died, 31st December 2014, or the date of the earliest record meeting the case 
definition for diagnosis of vitamin D deficiency. 
 
 
Outcome 
 
Diagnosis of vitamin D deficiency was defined as a record of any one of the following criteria 
in the THIN medical record: (1) a Read code related to vitamin D deficiency or rickets; (2) 
prescription of vitamin D (calciferol) at a ‘treatment dose’ (see below); or (3) a serum 25-
hydroxyvitamin D (25-OH-D) test result <25 nmol/L (<10 ng/ml). Read code lists were 
developed using published guidelines.15 GPs do not always record diagnoses using Read 
codes, instead entering data as free text which is not routinely accessible.16 Using Read codes 
alone to identify cases can result in case under-ascertainment, therefore we also included 
prescription and test records in the case definition. 
 
In order to capture prescriptions of colecalciferol or ergocalciferol issued for the treatment of 
established deficiency, as opposed to prophylactic supplementation or maintenance therapy, 
we used the following dose thresholds: (1) ≥1500 units/day if age <6 months; (2) ≥3000 
units/day if age 6 months to 12 years; (3) ≥5000 units/day if age >12 years; (4) one-off (stoss) 
 dose of ≥100 000 units at any age. These thresholds are higher than doses recommended for 
prophylaxis of between 400-1000 units/day,17 and represent half of the British National 
Formulary for Children treatment doses (≥3000 units/day if age 1-6 months, ≥6000 units/day 
if age 6 months to 12 years, and ≥10 000 units/day if age >12 years).18 A range of alternative 
dosage thresholds were explored using sensitivity analyses. The threshold of <25 nmol/L for 
25-OH-D tests represents deficiency in UK guidance.17,19 
  
Sensitivity analysis was performed additionally including ICD-10 codes for vitamin D 
deficiency and rickets from HES inpatient records in the case definition. This analysis was 
limited to follow-up to 31st December 2011. 
 
 
Covariates 
 
Socioeconomic position (SEP) was measured using the 2004 Index of Multiple Deprivation 
(IMD), an area-level indicator available in national quintiles.20 Recording of ethnicity in 
primary care databases is incomplete, but can be augmented by linkage with HES data.21 
Ethnicity was grouped into the 2001 UK Census 5-category classification (white, mixed, 
Asian, black, or other). As consistency of ethnicity recording is greater in primary care data 
than HES, ethnicity was assigned from THIN where available, and supplemented with HES 
data.21 For individuals with multiple ethnicity categories recorded (0.3% of the cohort), the 
most frequently recorded category was used. 
 
For children with missing ethnicity, maternal ethnicity was taken as a proxy measure for the 
child if available. Child-mother linkage was performed using similar methods to previous 
THIN studies.22,23 Children were linked to women sharing identical household identifiers with 
 a pregnancy or delivery record where the expected or recorded date of delivery was in 
proximity to the child’s month of birth. Linked mothers were excluded if children matched to 
several women (0.3% of linked children), or >20 people shared the same household identifier 
(likely to represent a block of flats). 
 
 
Statistical Analysis 
 
Crude incidence rates were calculated for each year between 2000-2014. Differences in rates 
by sex, age group (<5, 5-9, 10-14, and 15-17 years), ethnicity, IMD, and calendar year were 
examined using multivariable Poisson regression. Multivariable analysis was limited to 
follow-up between 2008-2014, due to small numbers of cases per year before 2008. 
Interactions between explanatory variables were examined, and interaction terms retained in 
the final model if their inclusion resulted in both a qualitative change in parameter rate ratios 
and a significant likelihood ratio test (p<0.05). The multivariable model was run with and 
without inclusion of the general practice as a random effect to account for data clustering.  
 
Missing data for ethnicity and IMD was handled using complete cases in the main analysis, 
and using multivariable multiple imputation for sensitivity analysis.24 The imputation model 
included all variables in the substantive model, plus auxiliary variables coding geographical 
region, and the ethnicity and IMD distributions of practice patients and of individuals sharing 
identical household identifiers. Analyses were performed using Stata 13.1 (StataCorp, College 
Station, TX). 
 
 The THIN data collection was approved by the NHS South-East Multicentre Research Ethics 
Committee in 2003. This study was approved by CSD Medical Research’s Scientific Review 
Committee. 
 
 
Results 
 
The study cohort contained 711 788 children from 156 practices, of whom 2918 were 
diagnosed with vitamin D deficiency between 2000-2014. Median observation time was 3.9 
years (interquartile range 1.5-8.0). Descriptive characteristics are shown in Table 1.  
 
Analysis of time trends showed a marked increase in diagnosis of vitamin D deficiency after 
2007 (Figure 1, and Supplemental Table 3). The crude incidence rate increased from 3.14 per 
100 000 person-years at risk (PYAR) in 2000 (95% confidence interval [CI]: 1.31-7.54) to 
261 per 100 000 PYAR in 2014 (95% CI: 241-281). After accounting for temporal changes in 
socio-demographic factors, a 15-fold increase in diagnosis (95% CI: 10-21 fold) was seen 
between 2008-2014 (Table 2). 
 
Supplemental Figure 2 shows the overlap between cases identified from diagnosis codes, 
prescription records, and 25-OH-D test records. Results did not differ substantially in 
sensitivity analyses using alternative dosage thresholds for calciferol prescriptions 
(Supplemental Figure 3), or addition of ICD-10 diagnosis codes from HES inpatient records 
(Supplemental Figure 4), in the case definition. 
 
In multivariable analysis older age, non-white ethnicity, and socioeconomic deprivation were 
associated with higher rates of vitamin D deficiency diagnosis (Table 2). There was an 
 interaction between sex and age; among children aged ≥10 years diagnosis rates were higher 
in girls, whilst among children aged <5 years they were higher in boys (Supplemental Figure 
5). No sex difference was seen in children aged 5-9 years. Although the magnitude of the 
effects of ethnicity and SEP were attenuated after accounting for clustering by practice, they 
remained strongly associated with the outcome (Table 2). There was a moderate proportion of 
missing data for ethnicity (12.7%) and IMD (8.3%). The results of analyses using multiple 
imputation were very similar to the main analyses using complete cases (Supplemental Table 
4). 
 
 
Discussion 
 
In this large representative cohort of English children, there was a 15-fold increase in the 
diagnosis of vitamin D deficiency between 2008-2013, after which rates plateaued. Socio-
demographic factors independently associated with higher rates of diagnosis included non-
white ethnicity, socioeconomic deprivation, older age, female sex in children aged ≥10 years, 
and male sex in children aged <5 years. 
 
 
Comparison with Other Studies 
 
To the best of our knowledge, this is the first study to report national estimates for overall 
rates of diagnosis of vitamin D deficiency in clinical practice, in the UK or internationally. 
However, a number of studies have investigated the incidence of clinical complications of 
vitamin D deficiency in children. The annual incidence of symptomatic vitamin D deficiency 
presenting to paediatricians was reported to be 7.5 per 100 000 children aged 0-5 years in the 
 West Midlands region of England, and between 2.2 to 2.9 per 100,000 children in New 
Zealand,25 Denmark,26 and Canada.27 The annual incidence of hypocalcaemic seizures 
secondary to vitamin D deficiency was 3.49 per million children age 0-15 years in the UK.28  
 
Vitamin D deficiency was diagnosed considerably more frequently in Asian and black 
compared to white children, which was expected given that they have lower vitamin D levels 
and higher risk of symptomatic deficiency.28–30 Diagnosis was also more frequent in children 
from deprived backgrounds. Low SEP is associated with suboptimal vitamin D status in 
children independent of ethnicity, and with reduced use of vitamin D supplements.31–33 The 
magnitude of the effects of ethnicity and SEP were attenuated after accounting for clustering 
by practice. One explanation for this observation is that the socio-demographic characteristics 
of a practice population may have contextual effects on clinicians’ diagnostic behaviour, 
separate from the influence of individual patients’ characteristics. GPs working in practices 
with more deprived and ethnically diverse populations may be more likely to test for vitamin 
D deficiency even in low-risk patients, because of increased awareness of the condition. 
Possible explanations for greater diagnosis in older compared to younger children may 
include more frequent presentation to healthcare services with chronic pain or other medically 
unexplained symptoms,34,35 and higher thresholds for requesting vitamin D tests in younger 
children in primary care due to the practical challenges of phlebotomy. Among older children, 
factors contributing to higher diagnosis rates in girls compared to boys may include higher 
overall primary care consultation rates,36 and the influence of cultural dress in some 
communities. 
 
 
Strengths and Limitations 
 
 Study strengths include the large sample size, and use of a prospectively collected database of 
healthcare records representative of real life clinical practice. As the THIN cohort has a 
similar age and sex distribution to the general population, our results should be broadly 
generalisable to England as a whole. However, it is somewhat over-representative of 
individuals from more affluent areas,10 therefore the observed diagnosis rates may 
underestimate true national rates to an extent. The inclusion of vitamin D prescriptions and 
tests in the case definition allowed identification of children where the diagnosis was not 
recorded using Read codes, helping to minimise case under-ascertainment. However, some 
cases may still have been missed, for example children who were diagnosed and received 
their full course of treatment in secondary care, if the diagnosis was not subsequently entered 
into the primary care record from hospital correspondence. Missing data for ethnicity was 
minimised by utilising linked HES data, and taking maternal ethnicity as a proxy measure 
where the child’s ethnicity was not available. However, the risk of misclassification will be 
greater where maternal ethnicity was used. Although there was a moderate proportion of 
missing data for ethnicity and IMD, complete case analysis and multiple imputation gave very 
similar results, suggesting that missing data did not substantially influence the findings under 
the missing at random assumption.24 Data was not available regarding other factors, such as 
body mass index, that are associated with vitamin D status and may influence testing in 
clinical practice. 
 
 
Clinical Implications 
 
Given the magnitude of the increase in diagnosis of vitamin D deficiency over a short period 
of time, it is very unlikely to be explained by changes in population vitamin D levels, 
incidence of clinical complications of vitamin D deficiency, or population demographics. It is 
 likely that the rise in testing and treatment has been driven by increased awareness and 
consideration of vitamin D deficiency among clinicians’. There are several possible 
contributing factors for this: clinician education through the development of clinical 
guidelines and dissemination of Department of Health recommendations concerning vitamin 
D supplementation for high risk groups,37 and wide reporting in the lay media and medical 
literature of research suggesting a link between vitamin D status and numerous non-
musculoskeletal health outcomes.38 
 
The data available did not permit exploration of the clinical indications prompting 
investigation of vitamin D status. We do not know how much the increase in diagnosis is 
being driven by improved recognition of children with clinical features consistent with 
symptomatic vitamin D deficiency, or by testing in other clinical situations (for example 
screening of asymptomatic children, or testing prompted by the presence of non-
musculoskeletal diseases that have been linked to vitamin D deficiency such as diabetes, 
atopic disorders, and infectious diseases). Sharp increases in vitamin D test requests in adults 
have been reported in Australia and the UK over the last decade.5,6 The introduction of a 
defined set of clinical criteria permitting 25-OH-D testing in Alberta, Canada, in 2015 
resulted in a 92% reduction in the number of tests ordered, and annual cost savings of almost 
4 million US dollars.39 This suggests that, prior to the intervention, the majority of vitamin D 
tests in adults were performed in individuals without specific clinical features or risk factors 
for deficiency. Further studies are required to explore the reasons for investigation of vitamin 
D status in children in clinical practice. 
 
Biochemical vitamin D deficiency, as defined by current guidelines, has a high prevalence in 
the general population, and testing in any patient group is likely to identify a significant 
proportion of abnormal results.4 Whilst the benefits of treatment with pharmacological doses 
 of vitamin D are clear in children with symptomatic deficiency, there is no evidence that 
testing and treating asymptomatic individuals results in improved health outcomes compared 
to prophylaxis with low-dose supplements.4,40 Whilst numerous observational studies have 
reported associations between low serum 25-OH-D levels and increased risk of various non-
musculoskeletal diseases, their results are subject to reverse causality, confounding and bias, 
and findings from RCTs are generally null or inconsistent.5,40–42 The UK Scientific Advisory 
Committee on Nutrition (SACN), US Institute of Medicine, and European Society for 
Pediatric Gastroenterology, Hepatology, and Nutrition have concluded that there is 
insufficient evidence of a causative role for vitamin D deficiency in the aetiology of non-
musculoskeletal health outcomes.40,43,44 Furthermore, there is limited evidence that optimising 
vitamin D status is beneficial for the management of these conditions once they have 
developed, for example in improving glycaemic control in diabetes or reducing disease 
severity in asthma.45,46 
 
The UK National Institute for Health and Care Excellence, US Endocrine Society, and 
European Society for Paediatric Endocrinology recommend that vitamin D status should not 
be checked as a routine screening test,47–49 a position supported by the Choosing Wisely 
campaigns in North America and Australia.50–52 Shaw and Mughal proposed a set of clinical 
indications for the measurement of 25-OH-D in children, which relate to symptoms and signs 
directly attributable to vitamin D deficiency, biochemical or radiological evidence of 
metabolic bone disease, or the presence of disorders that can interfere with vitamin D 
metabolism.4 Testing outside of this context requires careful consideration of whether vitamin 
D deficiency is related to the child’s presentation or is a coincidental finding. The 
interpretation of 25-OH-D results is further complicated by the inconsistency of commonly 
used laboratory assays and the limited evidence base underpinning the threshold values used 
to define deficiency.40,43,44,53 At the population level, unnecessary testing can result in 
 avoidable costs from the tests themselves and from prescription of pharmacological doses of 
vitamin D. From a public health perspective, resources may be better used if directed towards 
improving the currently low uptake of inexpensive vitamin D supplements, recommended by 
SACN and the American Academy of Pediatrics for the prevention of deficiency, by pregnant 
women and young children,54,55 particularly among high-risk ethnic groups.48,56  
 
 
Conclusions 
 
There has been a marked increase in the testing and diagnosis of vitamin D deficiency in 
children in England over the last decade. Future research should explore the drivers for this 
change in clinicians’ diagnostic behaviour, and the reasons prompting investigation of 
vitamin D status in clinical practice.  
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 FIGURE 1  Time Trends in the Diagnosis of Vitamin D Deficiency in Children, 2000 to 
2014.  Crude incidence rates are shown, with 95% confidence limits represented by the 
dashed lines. 
 
 
  
 TABLE 1  Descriptive Characteristics of the Study Cohort (n=711 788) 
Characteristic Value  
Age at entry to follow-up, years, median (IQR) 4.1  (0.40-10.5) 
Sex, n (%)  
 Male 366 378  (51.5) 
 Female 345 410  (48.5) 
Ethnicity, n (%)a   
 White 491 962  (69.1) 
 Asian or Asian British 34 521  (4.9) 
 Black or black British 24 797  (3.5) 
 Mixed 15 558  (2.2) 
 Chinese or other ethnic group 13 443  (1.9) 
 Missing 131 507  (18.5) 
Index of multiple deprivation quintile, n (%):  
 1 (least deprived) 158 866  (22.3) 
 2 134 765  (18.9) 
 3 138 264  (19.4) 
 4 136 498  (19.2) 
 5 (most deprived) 95 656  (13.4) 
 Missing 47 739  (6.7) 
IQR, interquartile range  
a Ethnicity data were available from the child’s THIN or HES record for 67.7% 
of the cohort, and maternal ethnicity was available as a proxy measure for 
13.8%. 
 
  
 TABLE 2  Associations Between Socio-Demographic Factors and Diagnosis of Vitamin D 
Deficiency (n=414 182)a 
 Single-level Model  Multilevel Model 
Characteristic 
Adjusted IRRb 
(95% CI) 
P valuec 
 Adjusted IRRb 
(95% CI) 
P valuec 
Sex, stratified by age group  <0.001   <0.001 
 0-4 years: Male 1  1 
  Female 0.73 (0.57-0.93)  0.72 (0.57-0.92) 
 5-9 years: Male 1  1 
  Female 1.06 (0.87-1.29)  1.04 (0.86-1.27) 
 10-14 years: Male 1  1 
  Female 1.97  (1.71-2.27)  1.97 (1.71- 2.27) 
 15-17 years: Male 1  1 
  Female 2.60  (2.18-3.11)  2.65 (2.21-3.16) 
Age group, stratified by sex  <0.001   <0.001 
 Males 0-4 years 1   1  
  5-9 years 1.22 (0.99-1.50)   1.20 (0.98-1.48)  
  10-14 years 2.22 (1.83-2.70)   2.19 (1.80-2.65)  
  15-17 years 2.39 (1.93-2.96)   2.36 (1.90-2.93)  
 Females: 0-4 years 1   1  
  5-9 years 1.77 (1.41-2.23)   1.73 (1.37-2.18)  
  10-14 years 6.00 (4.91-7.34)   5.95 (4.86-7.27)  
  15-17 years 8.52 (6.93-10.5)   8.61 (7.00-10.6)  
Ethnicityd  <0.001   <0.001 
 White 1   1  
 Asian or Asian British 22.4 (20.1-24.9)   7.98 (6.98-9.13)  
 Black or black British 14.2 (12.5-16.2)   5.47 (4.70-6.37)  
 Mixed 5.64 (4.52-7.03)   2.99 (2.38-3.76)  
 Chinese or other ethnic group 8.91 (7.38-10.8)   3.63 (2.96-4.45)  
IMD quintile  <0.001   <0.001 
 1 (least deprived) 1   1  
 2 1.98 (1.63-2.41)   1.34 (1.07-1.67)  
 3 2.40 (2.00-2.88)   1.41 (1.12-1.77)  
 4 2.67 (2.23-3.20)   1.63 (1.29-2.05)  
 5 (most deprived) 3.54 (2.96-4.24)   1.96 (1.52-2.53)  
Calendar year  <0.001   <0.001 
 2008 1   1  
 2009 2.20 (1.45-3.35)   2.19 (1.44-3.34)  
 2010 3.87 (2.62-5.71)   3.66 (2.48-5.40)  
 2011 6.61 (4.55-9.60)   6.28 (4.32-9.12)  
 2012 12.7 (8.83-18.2)   12.1 (8.43-17.4)  
 2013 14.7 (10.2-21.1)   14.1 (9.85-20.3)  
 2014 14.7 (10.2-21.2)   15.7 (10.9-22.6)  
CI, confidence interval; IMD, Index of Multiple Deprivation; IRR, incidence rate ratio. 
a Results of multivariable Poisson regression models of rates of incident diagnosis of vitamin D 
deficiency. Missing data is handled using complete cases analysis. 
b Adjusted for all variables listed in the table, including an interaction term between age and sex 
(likelihood ratio test for interaction p value<0.001). The multilevel model additionally included the 
general practice as a random effect. 
c P values from likelihood ratio tests comparing nested models. 
d Ethnicity data was taken from the child’s THIN or HES record for 84.6% of children. Maternal 
ethnicity was used as a proxy measure for the remaining 15.4%. 
 
  
 SUPPLEMENTAL TABLE 3  Crude incidence rates for the diagnosis of 
vitamin D deficiency in children, by year between 2000 and 2014. 
Year 
Number of Children 
Diagnosed with 
Vitamin D Deficiency 
Person Years at 
Risk (PYAR) 
Rate per 100 000 
PYAR (95% CI) 
2000 5 159 318 3.14  (1.31-7.54) 
2001 5 177 945 2.81  (1.17-6.75) 
2002 9 208 386 4.32  (2.25-8.30) 
2003 8 219 036 3.65  (1.83-7.30) 
2004 18 231 690 7.77  (4.89-12.3) 
2005 12 240 543 4.99  (2.83-8.78) 
2006 28 247 374 11.3  (7.82-16.4) 
2007 27 253 053 10.7  (7.32-15.6) 
2008 54 260 812 20.7  (15.9-27.0) 
2009 110 266 102 41.3  (34.3-49.8) 
2010 212 273 217 77.6  (67.8-88.8) 
2011 351 279 387 126  (113-139) 
2012 673 283 111 238  (220-256) 
2013 761 277 985 274  (255-293) 
2014 645 247 604 261  (241-281) 
CI, confidence interval 
  
 SUPPLEMENTAL TABLE 4  Associations between socio-demographic factors and 
diagnosis of vitamin D deficiency, with missing data handled using multiple imputation 
(n=511 868).a 
 Single-level Model  Multilevel Model 
Characteristic 
Adjusted IRRb 
(95% CI) 
P valuec 
 Adjusted IRRb 
(95% CI) 
P valuec 
Sex, stratified by age group  <0.001   <0.001 
 0-4 years: Male 1  1 
  Female 0.78 (0.64-0.97)  0.78 (0.63-0.96) 
 5-9 years: Male 1  1 
  Female 1.18 (1.00-1.41)  1.18 (1.00-1.40) 
 10-14 years: Male 1  1 
  Female 1.98 (1.75-2.24)  1.99 (1.76-2.25) 
 15-17 years: Male 1  1 
  Female 2.57 (2.20-3.00)  2.63 (2.25-3.06) 
Age group, stratified by sex  <0.001   <0.001 
 Males 0-4 years 1   1  
  5-9 years 1.28 (1.07-1.54)   1.26 (1.05-1.52)  
  10-14 years 2.30 (1.94-2.72)   2.26 (1.90-2.67)  
  15-17 years 2.39 (1.98-2.89)   2.37 (1.96-2.87)  
 Females: 0-4 years 1   1  
  5-9 years 1.94 (1.60-2.26)   1.92 (1.58-2.33)  
  10-14 years 5.81 (4.89-6.91)   5.77 (4.85-6.86)  
  15-17 years 7.82 (6.54-9.36)   8.00 (6.68-9.56)  
Ethnicityd  <0.001   <0.001 
 White 1   1  
 Asian or Asian British 21.8 (19.8-24.0)   7.14 (6.31-8.07)  
 Black or Black British 15.3 (13.6-17.1)   5.42 (4.74-6.20)  
 Mixed 5.85 (4.80-7.14)   2.97 (2.42-3.65)  
 Chinese or other ethnic group 8.56 (7.18-10.2)   3.41 (2.82-4.13)  
IMD quintilee  <0.001   <0.001 
 1 (least deprived) 1   1  
 2 2.01 (1.67-2.42)   1.33 (1.08-1.65)  
 3 2.48 (2.08-2.95)   1.47 (1.18-1.83)  
 4 2.94 (2.48-3.49)   1.70 (1.36-2.13)  
 5 (most deprived) 4.51 (3.82-5.32)   1.94 (1.52-2.48)  
Calendar year  <0.001   <0.001 
 2008 1   1  
 2009 1.95 (1.41-2.71)   1.95 (1.40-2.70)  
 2010 3.54 (2.62-4.78)   3.34 (2.47-4.51)  
 2011 5.63 (4.21-7.51)   5.34 (4.00-7.13)  
 2012 10.4 (7.87-13.8)   9.95 (7.52-13.2)  
 2013 11.8 (8.93-15.6)   11.4 (8.63-15.1)  
 2014 12.2 (9.21-16.1)   12.9 (9.70-17.0)  
CI, confidence interval; IMD, Index of Multiple Deprivation; IRR, incidence rate ratio. 
a Results of multivariable Poisson regression models of rates of incident diagnosis of vitamin D 
deficiency. Missing data is handled using multivariable multiple imputation using chained equations. 
b Adjusted for all variables listed in the table, including an interaction term between age and sex 
(likelihood ratio test for interaction p value<0.001). The multilevel model additionally included the 
general practice as a random effect. 
c P values from likelihood ratio tests comparing nested models. 
d Ethnicity data was available from the child’s THIN or HES record for 73.4% of children, from 
maternal ethnicity as a proxy measure for 13.9%, and was imputed for the remaining 12.7%. 
e IMD was available from the THIN record for 91.7% of children, and was imputed for 8.3%.  
  
SUPPLEMENTAL FIGURE 2  Overlap between sources of case identification. VDD 
indicates vitamin D deficiency. Figures represent numbers (percentages). n=2918  
  
SUPPLEMENTAL FIGURE 3  Time trends in the diagnosis of vitamin D deficiency in 
children, using different dosage thresholds for calciferol prescription in the case definition. 
Crude incidence rates are shown, between 2000 and 2014. Case definition 1 is that used in the 
main analysis, in which the calciferol dosage thresholds are as follows: ≥1500 units/day if age 
<6 months, ≥3000 units/day if age 6 months to 12 years, ≥5000 units/day if age >12 years, or 
one-off (stoss) dose of ≥100 000 units at any age. In case definition 2 the dosage thresholds 
are: ≥1000 units/day if age <6 months, ≥2000 units/day if age 6 months to 12 years, ≥3000 
units/day if age >12 years, or one-off dose of ≥100 000 units at any age. In case definition 3 
the dosage thresholds are: ≥3000 units/day if age <6 months, ≥6000 units/day if age 6 months 
to 12 years, ≥10 000 units/day if age >12 years, or one-off dose of ≥100 000 units at any age. 
  
  
SUPPLEMENTAL FIGURE 4  Time trends in the diagnosis of vitamin D deficiency in 
children, with and without the inclusion of ICD-10 codes related to vitamin D deficiency or 
rickets from HES admitted patient care records in the case definition. Crude incidence rates 
are shown. THIN indicates The Health Improvement Network, HES indicates Hospital 
Episode Statistics, and ICD-10 indicates The International Classification of Diseases 10th 
Revision. The analysis was limited to follow-up between 2000 and 2011, as linked HES data 
is only available up to 31st March 2012. 
  
  
SUPPLEMENTAL FIGURE 5  Adjusted predicted incidence rates for the diagnosis of 
vitamin D deficiency in children across categories of age, showing an interaction with sex.  
Predicted margins were derived from a multivariable Poisson regression model at average 
values for the remaining covariates (ethnicity, Index of Multiple Deprivation, and calendar 
year). The vertical bars represent 95% confidence intervals. 
 
 
